WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Ionis Pharmaceuticals revenue was $803.07M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $133.8M, down 40.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IONS annual revenue was $787.6M, with 34.1% growth year-over-year.

IONS past revenue growth

How has IONS's revenue growth performed historically?

Company
30.57%
Industry
1,112.46%
Market
34.78%
IONS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IONS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IONS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IONS revenue history

Current Revenue
$803.1M
Current Earnings
-$358.8M
Current Profit Margin
-44.7%

Be the first to know when IONS announces revenue.

IONS Revenue History By Year

IONS Yearly RevenueIONS RevenueIONS ChangeIONS Revenue Growth
2023-12-31$787.65M$200.28M+34.10%
2022-12-31$587.37M-$223.09M-27.53%
2021-12-31$810.46M$81.19M+11.13%
2020-12-31$729.26M-$393.34M-35.04%
2019-12-31$1.12B$522.93M+87.20%
2018-12-31$599.67M$85.50M+16.63%
2017-12-31$514.18M$141.40M+37.93%
2016-12-31$372.78M$89.07M+31.40%
2015-12-31$283.70M$69.54M+32.47%
2014-12-31$214.16M$66.88M+45.41%
2013-12-31$147.29M$45.24M+44.33%
2012-12-31$102.05M$2.96M+2.99%
2011-12-31$99.09M-$9.39M-8.65%
2010-12-31$108.47M-$13.13M-10.80%
2009-12-31$121.60M$14.41M+13.44%
2008-12-31$107.19M$48.85M+83.72%
2007-12-31$58.34M$43.49M+292.65%
2006-12-31$14.86M-$25.27M-62.98%
2005-12-31$40.13M-$2.49M-5.84%
2004-12-31$42.62M-$7.37M-14.73%
2003-12-31$49.99M-$30.19M-37.65%
2002-12-31$80.18M$26.91M+50.51%
2001-12-31$53.27M$16.02M+43.00%
2000-12-31$37.26M$3.33M+9.82%
1999-12-31$33.93M-$5.25M-13.39%
1998-12-31$39.17M$6.45M+19.71%
1997-12-31$32.72M$10.06M+44.39%
1996-12-31$22.66M$6.70M+41.94%
1995-12-31$15.97M$454.00k+2.93%
1994-12-31$15.51MN/AN/A

1 of 2

Ionis Pharmaceuticals Revenue FAQ

What was IONS's revenue last quarter?

On Invalid Date, Ionis Pharmaceuticals (NASDAQ: IONS) reported Q3 2024 revenue of $133.81 million up 7.21% year over year. In the same quarter last year, Ionis Pharmaceuticals's revenue was $144.21 million.

What was Ionis Pharmaceuticals's revenue in 2023?

Ionis Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2023 was $787.65 million, a 34.1% increase year over year.

How much does Ionis Pharmaceuticals make in a day?

Based on Ionis Pharmaceuticals annual revenue for the past five years, IONS makes an average of $2,212,237.26 per day.

What was Ionis Pharmaceuticals's annual revenue growth in the past year?

As of Q1 2025, Ionis Pharmaceuticals's revenue has grown 30.57% year over year. This is 1,081.88 percentage points lower than the US Biotechnology industry revenue growth rate of 1,112.46%. Ionis Pharmaceuticals's revenue in the past year totaled $803.07 million.

How much does Ionis Pharmaceuticals make in a year?

Ionis Pharmaceuticals's revenue by year for the past five years is:
  • Ionis Pharmaceuticals's revenue for the twelve months ending Dec 31, 2023 was $787.65 million, a 34.1% increase year over year.
  • Ionis Pharmaceuticals's annual revenue for Dec 31, 2022 was $587.37 million, a 27.53% decrease from 2021.
  • Ionis Pharmaceuticals's annual revenue for 2021 was $810.46 million, a 11.13% increase from 2020.
  • Ionis Pharmaceuticals's annual revenue for 2020 was $729.26 million, a 35.04% decrease from 2019.
  • Ionis Pharmaceuticals's annual revenue for 2019 was $1.12 billion, a 87.2% increase from 2018.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.